Cargando…

Targeting LIM kinase in cancer and neurofibromatosis

Detalles Bibliográficos
Autores principales:	Rak, Roni, Kloog, Yoel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2014
Materias:	Editorials: Cell Cycle Features
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4050127/ https://www.ncbi.nlm.nih.gov/pubmed/24698779 http://dx.doi.org/10.4161/cc.28748

Ejemplares similares

Intercellular transfer of Ras: Implications for immunity
por: Goldstein, Itamar, et al.
Publicado: (2014)

PARty promoters: Hormone-dependent gene regulation requires CDK2 activation of PARP1
por: Wright, Roni H.G., et al.
Publicado: (2012)

To target or not to target the enemy within localized prostate cancer
por: Risbridger, Gail, et al.
Publicado: (2013)

Anchoring proteins encounter mitotic kinases
por: Canton, David A., et al.
Publicado: (2013)

Integrin-linked kinase in ciliary Hedgehog signaling
por: Hannigan, Gregory E
Publicado: (2014)

PKM2 functions as a histone kinase
por: Lu, Zhimin
Publicado: (2012)

Targeting genetic lesions in esophageal cancer
por: Lin, De-Chen, et al.
Publicado: (2014)

Protein kinase CK2 opens the gate for zinc signaling
por: Taylor, Kathryn M., et al.
Publicado: (2012)

The CDK-activating kinase Cdk7: Taking yes for an answer
por: Schachter, Miriam Merzel, et al.
Publicado: (2013)

Targeting the Achilles’ heel of drug-resistant cancer stem cells
por: Seguin, Laetitia, et al.
Publicado: (2014)

Skp2: A dream target in the coming age of cancer therapy
por: Chan, Chia-Hsin, et al.
Publicado: (2014)

Two new kinases in the TOR signaling network regulate ribosome and tRNA synthesis
por: Willis, Ian M., et al.
Publicado: (2012)

p85β increases phosphoinositide 3-kinase activity and accelerates tumor progression
por: González-García, Ana, et al.
Publicado: (2012)

Targeting cancer cells resistant to hypoxia and nutrient starvation to improve anti-angiogeneic therapy
por: Osawa, Tsuyoshi, et al.
Publicado: (2013)

Revealing targeted therapeutic opportunities in triple-negative breast cancers: A new strategy
por: Poage, Graham M, et al.
Publicado: (2013)

Unique and redundant roles of class I(A) PI3Kinase regulatory subunits in mast cell development
por: Mali, Raghuveer Singh, et al.
Publicado: (2013)

Targeted cholesterol efflux
por: Fang, Longhou, et al.
Publicado: (2013)

Targeting the intratumor heterogeneity in PMBL
por: Ritz, Olga, et al.
Publicado: (2014)

Molecular targeting of mutagenic AID and APOBEC deaminases
por: Nabel, Christopher S, et al.
Publicado: (2014)

Oncogene interference through targeting of chromatin regulators
por: Roe, Jae-Seok, et al.
Publicado: (2013)

BRD4: A BET(ter) target for the treatment of AML?
por: Valent, Peter, et al.
Publicado: (2014)

Target search dynamics during post-replicative mismatch repair
por: Gorman, Jason, et al.
Publicado: (2013)

Arsenic reverses glioblastoma resistance to mTOR-targeted therapies
por: Iwanami, Akio, et al.
Publicado: (2013)

DNA looping-dependent targeting of a chromatin remodeling factor
por: Yadon, Adam N., et al.
Publicado: (2013)

Bringing target-matched PI3King from the bench to the clinic
por: Janku, Filip
Publicado: (2013)

Lipid-cell cycle nexus: SREBP regulates microRNAs targeting Fbxw7
por: Esquejo, Ryan M, et al.
Publicado: (2014)

Nucleotide excision DNA repair pathway as a therapeutic target in patients with high-risk diffuse large B cell lymphoma
por: Bret, Caroline, et al.
Publicado: (2013)

The metabolic facet of pancreatic cancer: How hypoxia shapes fatal cancer cells
por: Guillaumond, Fabienne, et al.
Publicado: (2013)

Vaccines and early breast cancer
por: Caballero, Otavia L, et al.
Publicado: (2014)

“Sister” miRNAs in cancers
por: Wahdan-Alaswad, Reema, et al.
Publicado: (2013)

MET in ovarian cancer: Metastasis and resistance?
por: Tang, Chad, et al.
Publicado: (2014)

The bright side of ascites in ovarian cancer
por: Cohen, Marie, et al.
Publicado: (2014)

Oxidizing to death: Disulfiram for cancer cell killing
por: Brüning, Ansgar, et al.
Publicado: (2014)

Cancer germline gene activation: Friend or foe?
por: McFarlane, Ramsay J, et al.
Publicado: (2014)

BETting on a new prostate cancer treatment
por: Asangani, Irfan A, et al.
Publicado: (2014)

MAPK signaling control of colon cancer metastasis
por: Urosevic, Jelena, et al.
Publicado: (2014)

TLS/FUS: A protein in cancer and ALS
por: Tan, Adelene Y., et al.
Publicado: (2012)

Restoring PML tumor suppression to combat cancer
por: Wolyniec, Kamil, et al.
Publicado: (2012)

CRH-R splicing in estrogen-sensitive breast cancer
por: Grammatopoulos, Dimitris K
Publicado: (2014)

Mitochondrial metabolism in TCA cycle mutant cancer cells
por: Sullivan, Lucas B, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hdgbegukmekm2kdi4sp8qtqski